×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
HOWL – werewolf therapeutics, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
HOWL
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
11/25
07:31 am
howl
Werewolf Therapeutics (NASDAQ:HOWL) was downgraded by analysts at Zacks Research from a "strong-buy" rating to a "hold" rating.
Medium
Report
Werewolf Therapeutics (NASDAQ:HOWL) was downgraded by analysts at Zacks Research from a "strong-buy" rating to a "hold" rating.
11/18
01:13 pm
howl
Werewolf Therapeutics (NASDAQ:HOWL) had its price target lowered by analysts at Bank of America Corporation from $8.00 to $7.00. They now have a "buy" rating on the stock.
Medium
Report
Werewolf Therapeutics (NASDAQ:HOWL) had its price target lowered by analysts at Bank of America Corporation from $8.00 to $7.00. They now have a "buy" rating on the stock.
11/12
08:05 am
howl
Werewolf Therapeutics (NASDAQ:HOWL) had its "market outperform" rating reaffirmed by analysts at Citigroup Inc..
Medium
Report
Werewolf Therapeutics (NASDAQ:HOWL) had its "market outperform" rating reaffirmed by analysts at Citigroup Inc..
11/7
09:00 am
howl
Werewolf Therapeutics Presents Data Expanding Its PREDATOR® Platform at the Society for Immunotherapy of Cancer’s (SITC) 40th Annual Meeting
Low
Report
Werewolf Therapeutics Presents Data Expanding Its PREDATOR® Platform at the Society for Immunotherapy of Cancer’s (SITC) 40th Annual Meeting
11/4
07:00 am
howl
Werewolf Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Update
Neutral
Report
Werewolf Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Update
10/18
07:31 am
howl
Werewolf Therapeutics (NASDAQ:HOWL) was upgraded by analysts at Zacks Research from a "hold" rating to a "strong-buy" rating.
Neutral
Report
Werewolf Therapeutics (NASDAQ:HOWL) was upgraded by analysts at Zacks Research from a "hold" rating to a "strong-buy" rating.
10/8
08:36 am
howl
Werewolf Therapeutics Receives Fast Track Designation from the U.S. FDA for WTX-124, an Investigational Therapy for the Treatment of Cancer [Yahoo! Finance]
Medium
Report
Werewolf Therapeutics Receives Fast Track Designation from the U.S. FDA for WTX-124, an Investigational Therapy for the Treatment of Cancer [Yahoo! Finance]
10/8
08:00 am
howl
Werewolf Therapeutics Receives Fast Track Designation from the U.S. FDA for WTX-124, an Investigational Therapy for the Treatment of Cancer
Low
Report
Werewolf Therapeutics Receives Fast Track Designation from the U.S. FDA for WTX-124, an Investigational Therapy for the Treatment of Cancer
Date
Time
Symbol
Company Name
Action
%Chg
11/4/2025
07:00 am
HOWL
werewolf therapeutics, inc.
BEAT
Report
0.0%
werewolf therapeutics, inc.
8/14/2025
07:00 am
HOWL
werewolf therapeutics, inc.
BEAT
Report
-2.1%
werewolf therapeutics, inc.
5/8/2025
07:00 am
HOWL
werewolf therapeutics, inc.
BEAT
Report
-6.8%
werewolf therapeutics, inc.
3/11/2025
07:00 am
HOWL
werewolf therapeutics, inc.
MISS
Report
6.7%
werewolf therapeutics, inc.
Date
Time
Action
From
To
Firm
Impact
%Chg
11/12
08:05 am
Reiterates
Market Outperform
Market Outperform
Citigroup Inc.
Medium
Report
-3.5%
Date
Time
Symbol
Headline
Impact
12/4
06:20 pm
howl
Form 4 Werewolf Therapeutics, For: Dec 02 Filed by: MPM BioVentures 2014 LLC
Low
Report
Form 4 Werewolf Therapeutics, For: Dec 02 Filed by: MPM BioVentures 2014 LLC
12/4
06:20 pm
howl
Form 4 Werewolf Therapeutics, For: Dec 02 Filed by: EVNIN LUKE
Low
Report
Form 4 Werewolf Therapeutics, For: Dec 02 Filed by: EVNIN LUKE
12/4
06:19 pm
howl
Form 4 Werewolf Therapeutics, For: Dec 02 Filed by: Oncology Impact Fund (Cayman) Management L.P.
Low
Report
Form 4 Werewolf Therapeutics, For: Dec 02 Filed by: Oncology Impact Fund (Cayman) Management L.P.
12/3
07:04 pm
howl
Form SCHEDULE 13D/A Werewolf Therapeutics, Filed by: MPM BioVentures 2014, L.P.
Medium
Report
Form SCHEDULE 13D/A Werewolf Therapeutics, Filed by: MPM BioVentures 2014, L.P.
12/3
04:40 pm
howl
Form 144 Werewolf Therapeutics, Filed by: MPM BioVentures 2014 (B), L.P.
High
Report
Form 144 Werewolf Therapeutics, Filed by: MPM BioVentures 2014 (B), L.P.
12/3
04:40 pm
howl
Form 144 Werewolf Therapeutics, Filed by: MPM ONCOLOGY INNOVATIONS FUND LP
High
Report
Form 144 Werewolf Therapeutics, Filed by: MPM ONCOLOGY INNOVATIONS FUND LP
12/3
04:40 pm
howl
Form 144 Werewolf Therapeutics, Filed by: MPM ASSET MANAGEMENT LLC
High
Report
Form 144 Werewolf Therapeutics, Filed by: MPM ASSET MANAGEMENT LLC
12/3
04:39 pm
howl
Form 144 Werewolf Therapeutics, Filed by: UBS Oncology Impact Fund L.P.
High
Report
Form 144 Werewolf Therapeutics, Filed by: UBS Oncology Impact Fund L.P.
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: